Robert Iannone's Net Worth
$7.2 Million
Who is Robert Iannone?
Robert Iannone has an estimated net worth of $7.2 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, iTeos Therapeutics, Inc., Jounce Therapeutics, Inc., and Jazz Pharmaceuticals plc.
SEC CIK
Robert Iannone's CIK is 0001737329
Past Insider Trading and Trends
2020 was Robert Iannone's most active year for acquiring shares with 6 total transactions. Robert Iannone's most active month to acquire stocks was the month of May. 2023 was Robert Iannone's most active year for disposing of shares, totalling 6 transactions. Robert Iannone's most active month to dispose stocks was the month of April. 2019 saw Robert Iannone paying a total of $0.00 for 119,590 shares, this is the most they've acquired in one year. In 2023 Robert Iannone cashed out on 78,535 shares for a total of $494,757.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNOMEDICS INC No price found
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.23
EVP, Global Head R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.46% | -4.29K |
$117.53 | -$504,673.82 | 62.23K |
Mar 5
| |||
Form 4
| +34.13% | 16.93K |
—
|
—
| 66.52K |
Mar 1
| |||
Form 4
| +9.35% | 4.24K |
$119.13 | -$206,094.90 | 49.59K |
Jan 17
| |||
Form 4
| -2.81% | -1.31K |
$129.73 | -$170,076.03 | 45.31K |
Jun 5
| |||
Form 4
| +28.01% | 10.17K |
$142.78 | -$324,681.72 | 46.49K |
Mar 3 - Mar 5
| |||
Form 4
| -4.83% | -1.84K |
$151.54 | -$279,439.76 | 36.32K |
Dec 9
| |||
Form 4
| -3.29% | -1.29K |
$149.25 | -$193,278.75 | 38.11K |
Jun 6
| |||
Form 4
| +34.40% | 10.05K |
$153.96 | -$204,304.92 | 39.26K |
Mar 3 - Mar 5
| |||
Form 4
| -3.98% | -1.21K |
$176.47 | -$212,822.82 | 29.09K |
Jun 5
| |||
Form 4
| -2.40% | -741.00 |
$164.75 | -$122,079.75 | 30.14K |
Mar 5
| |||
Form 4
| +38.19% | 8.54K |
—
|
—
| 30.89K |
Feb 25
| |||
Form 4
| -4.07% | -943.00 |
$120.65 | -$113,772.95 | 22.2K |
Jun 5
| |||
Form 4
| +88.52% | 10.8K |
—
|
—
| 23K |
Feb 27
| |||
Form 4
|
∞
| 12.2K |
—
|
—
| 12.2K |
Aug 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||